secwatch.observer — SEC 8-K summary
======================================

Issuer:     IO Biotech, Inc. (IOBTQ)
CIK:        0001865494
Form:       8-K
Filed at:   2023-03-14T23:59:59+00:00
Accession:  0001193125-23-069559
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IO Biotech reports ~$142M cash as of Dec 31, 2022; runway through Q3 2024
-------------------------------------------------------------------------

- Preliminary cash and cash equivalents of ~$142M as of Dec 31, 2022 (subject to audit).
- Cash runway projected through Q3 2024, per updated corporate presentation.
- Updated presentation to be used at Oppenheimer 33rd Annual Healthcare Conference on Mar 14, 2023.
- No other financial results or guidance changes disclosed; preliminary cash is unaudited.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1865494/000119312523069559/0001193125-23-069559-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1865494/000119312523069559/d486492d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-069559

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer